Cingulate Inc. Expands At-The-Market Offering to Raise Up to $8.84 Million, Signaling Significant Dilution
CING sits 51% above its 52-week low of $3.2.
Summary
Cingulate Inc. announced an expansion of its At-The-Market offering, enabling the sale of up to $8.84 million in common stock, which could lead to significant shareholder dilution.
Key Events · Financing and Capital Events · CING
-
Expanded ATM Offering
Cingulate Inc. can now sell up to an additional $8.84 million of common stock through its At-The-Market (ATM) offering program.
-
Significant Potential Dilution
The potential capital raise of $8.84 million is substantial relative to the company's market capitalization, indicating significant potential dilution for current shareholders.
-
Ongoing Capital Strategy
This filing updates a previously established ATM program, under which the company has already sold approximately $15.15 million in shares.
Analysis · CING · Life Sciences
Cingulate Inc. has expanded its At-The-Market (ATM) offering capacity, allowing it to sell up to an additional $8.84 million in common stock. This represents a substantial potential dilution for existing shareholders, given the company's current market capitalization. While raising capital is crucial for extending the company's operational runway, the continuous sale of shares through an ATM program can create an overhang on the stock price. Investors should monitor the pace and pricing of these sales as they occur.
How filings like this one have moved
In the 30 days to Sep 19, 2026, 34.8% of the 1128 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.41%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CING was trading at $4.84 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $32.9M. The 52-week trading range was $3.20 to $6.01. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.